We are live on ! Find out more
RDY icon

Dr. Reddy's Laboratories

174 hedge funds and large institutions have $1.41B invested in Dr. Reddy's Laboratories in 2015 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 64 increasing their positions, 58 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

53% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 15

10% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 58

9% more capital invested

Capital invested by funds: $1.3B → $1.41B (+$111M)

4% more funds holding

Funds holding: 168174 (+6)

3.37% less ownership

Funds ownership: 75.89%72.52% (-3.4%)

Holders
174
Holders Change
+6
Holders Change %
+3.57%
% of All Funds
4.64%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
23
Increased
64
Reduced
58
Closed
15
Calls
$58K
Puts
Net Calls
+$58K
Net Calls Change
+$58K

RDY Hedge Fund Activity: Q1 2015 in Review

174 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q1 2015, worth a combined $1.41B — up 8.5% from $1.3B a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new RDY positions and 15 closed out — a net gain of 8 holders — while 64 added to existing stakes and 58 trimmed.

The largest buyer was Fisher Asset Management, adding an estimated $56.4M. The largest seller was Fidelity International, cutting an estimated $34.8M.

  • 174 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q1 2015, up from 168 in Q4 2014.
  • Funds reported $1.41B of Dr. Reddy's Laboratories stock for Q1 2015, up 8.5% quarter-over-quarter.
  • 23 funds opened new Dr. Reddy's Laboratories positions in Q1 2015 and 15 closed out, a net change of +8 holders.
  • The largest Dr. Reddy's Laboratories buyer in Q1 2015 was Fisher Asset Management, an estimated $56.4M added.
  • The largest Dr. Reddy's Laboratories seller in Q1 2015 was Fidelity International, an estimated $34.8M sold.

Based on aggregated 13F filings for Q1 2015.